2 papers
q-bio.QM2024
Modeling therapy sequence for advanced cancer: A microsimulation approach leveraging Electronic Health Record data
Elizabeth A. Handorf, J. Robert Beck, Daniel M. Geynisman
Many patients with advanced cancers undergo multiple lines of treatment. We develop methods for estimating quality-adjusted outcomes and cost-effectiveness of therapy sequences, in…
stat.AP2022
Cost-effectiveness analysis for therapy sequence in advanced cancer: A microsimulation approach with application to metastatic prostate cancer
Elizabeth A. Handorf, J. Robert Beck, Andres Correa +2
Purpose. Patients with advanced cancer may undergo multiple lines of treatment, switching therapies as their disease progresses. Motivated by a study of metastatic prostate cancer,…